A multicenter, randomized, controlled, single‐blind comparison phase III study to determine the efficacy and safety of gadobutrol 1.0 M versus gadopentetate dimeglumine following single injection in patients referred for contrast‐enhanced MRI of the body regions or extremities

By  

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 41, Iss. 2, 2015-02 ,pp. : 404-413

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase 3 efficacy and safety trial of gadobutrol, a 1.0 molar macrocyclic MR imaging contrast agent, in patients referred for contrast‐enhanced MR imaging of the central nervous system

By  

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 41, Iss. 3, 2015-03 ,pp. : 788-796

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics, Efficacy and Safety of IMMUNATE® Solvent/Detergent (IMMUNATE® S/D) in Previously Treated Patients with Severe Hemophilia A: Results of a Prospective, Multicenter, Open-Label Phase III Study

By  

Acta Haematologica, Vol. 119, Iss. 2, 2008-02 ,pp. : 89-97

Karger

Access to resources Recommend Favorite

The efficacy and safety of cyclosporine reduction in de novo renal allograft patients receiving sirolimus and corticosteroids: results from an open‐label comparative study

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 27, Iss. 2, 2014-02 ,pp. : 176-186

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase 3, multicenter, randomized, allopurinol‐controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 6, 2015-07 ,pp. : 669-678

John Wiley & Sons Inc

Access to resources Recommend Favorite